BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32375465)

  • 1. Lineage switch from B lymphoblastic leukemia with
    Marco-Ayala J; Vicente AI; Such E; Luna I; Andreu R; Sempere A; Romero S; Peris MLS
    Blood Res; 2020 Jun; 55(2):75. PubMed ID: 32375465
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy- (Blinatumomab-) Related Lineage Switch of
    He RR; Nayer Z; Hogan M; Cuevo RS; Woodward K; Heyer D; Curtis CA; Peterson JF
    Case Rep Hematol; 2019; 2019():7394619. PubMed ID: 31885955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
    Kanayama T; Imamura T; Kawabe Y; Osone S; Tahara J; Iwasaki F; Miyagawa N; Goto H; Imashuku S; Hosoi H
    Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.
    Pincez T; Landry JR; Roussy M; Jouan L; Bilodeau M; Laramée L; Couture F; Sinnett D; Gendron P; Hébert J; Oligny L; Rouette A; Tran TH; Wilhelm BT; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2020 Feb; 59(2):125-130. PubMed ID: 31515871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
    Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated transcriptional networks in
    Kang H; Sharma ND; Nickl CK; Devidas M; Loh ML; Hunger SP; Dunsmore KP; Winter SS; Matlawska-Wasowska K
    Biomark Res; 2018; 6():27. PubMed ID: 30159143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further validation of poor prognosis for pediatric
    Goldman JW; Mody RJ
    Transl Pediatr; 2024 Feb; 13(2):370-375. PubMed ID: 38455748
    [No Abstract]   [Full Text] [Related]  

  • 8. Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement.
    Zoghbi A; Zur Stadt U; Winkler B; Müller I; Escherich G
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28453885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease.
    Forgione MO; McClure BJ; Eadie LN; Yeung DT; White DL
    Cancer Lett; 2020 Jan; 469():410-418. PubMed ID: 31705930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.
    Ikeda J; Shiba N; Tsujimoto SI; Yoshida M; Nakabayashi K; Ogata-Kawata H; Okamura K; Takeuchi M; Osumi T; Tomizawa D; Hata K; Kiyokawa N; Ito S; Kato M
    Genes Chromosomes Cancer; 2019 Sep; 58(9):669-672. PubMed ID: 30869817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of PI3-kinase/RAS Pathway Cooperating Mutations in the Evolution of
    Esposito MT
    Hemasphere; 2019 Jun; 3(3):e195. PubMed ID: 31723831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Leukemias of Ambiguous Lineage: Clarification on Lineage Specificity.
    Kurzer JH; Weinberg OK
    Surg Pathol Clin; 2019 Sep; 12(3):687-697. PubMed ID: 31352981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.
    Al-Kershi S; Bhayadia R; Ng M; Verboon L; Emmrich S; Gack L; Schwarzer A; Strowig T; Heckl D; Klusmann JH
    Blood Adv; 2019 Dec; 3(24):4252-4263. PubMed ID: 31867596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical peripheral blood stem cell transplantation without irradiation or busulfan after reduced-intensity conditioning for KMT2A(MLL)-rearranged infant B-cell precursor acute lymphoblastic leukemia: Report of two cases.
    Yoshimi A; Kato K; Hosaka S; Suzuki R; Fukushima H; Nakao T; Kobayashi C; Fukushima T; Koike K; Sumazaki R; Tsuchida M
    Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28332262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First case of B ALL with KMT2A-MAML2 rearrangement: a case report.
    Menu E; Beaufils N; Usseglio F; Balducci E; Lafage Pochitaloff M; Costello R; Gabert J
    BMC Cancer; 2017 May; 17(1):363. PubMed ID: 28535805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
    Attarbaschi A; Mann G; König M; Steiner M; Strehl S; Schreiberhuber A; Schneider B; Meyer C; Marschalek R; Borkhardt A; Pickl WF; Lion T; Gadner H; Haas OA; Dworzak MN
    Clin Cancer Res; 2006 May; 12(10):2988-94. PubMed ID: 16707593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy.
    Rayes A; McMasters RL; O'Brien MM
    Pediatr Blood Cancer; 2016 Jun; 63(6):1113-5. PubMed ID: 26914337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
    Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
    Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
    Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.